Bridger Management’s Cardiff Oncology CRDF Stock Holding History

Bridger Management’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-45,703	Closed	-$14.8M	–	40
2016 Q3	$14.8M	Hold	45,703	–	–	1%	32
2016 Q2	$14.9M	Hold	45,703	–	–	0.96%	32
2016 Q1	$15.3M	Hold	45,703	–	–	1.06%	30
2015 Q4	$17.8M	Hold	45,703	–	–	0.59%	29
2015 Q3	$18.7M	Buy	45,703 +1,945	+4%	+$1.02M	1.28%	28
2015 Q2	$32M	Buy	43,758 +4,167	+11%	+$2.96M	1.01%	28
2015 Q1	$19.4M	Buy	39,591 +9,829	+33%	+$4.19M	1.3%	30
2014 Q4	$9.21M	Hold	29,762	–	–	0.58%	37
2014 Q3	$9.81M	Hold	29,762	–	–	0.67%	37
2014 Q2	$7.5M	Hold	29,762	–	–	0.53%	34
2014 Q1	$12.3M	Hold	29,762	–	–	0.82%	35
2013 Q4	$12.3M	Hold	29,762	–	–	0.86%	34
2013 Q3	$15.4M	Buy	+29,762	New	+$16.9M	1.1%	34

Other funds holding CRDF

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Bridger Management's CRDF Position: Q4 2016 in Review

Bridger Management sold out of Cardiff Oncology (CRDF) in Q4 2016, closing a stake of 45,703 shares — an estimated $14.8M sold.

Bridger Management first reported a position in CRDF in Q3 2013 and held it in 13 quarters. The position peaked at $32M in Q2 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

Bridger Management reported no remaining Cardiff Oncology position as of Q4 2016 after selling out during the quarter.
Bridger Management sold 45,703 Cardiff Oncology shares in Q4 2016, an estimated $14.8M.
Bridger Management first reported a position in Cardiff Oncology in Q3 2013 and held it in 13 quarters.
Bridger Management's Cardiff Oncology position peaked at $32M in Q2 2015.
68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on Bridger Management's 13F filing for Q4 2016, filed 14 Feb 2017.